Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions ...

U.S. revenue in the fourth quarter of 2024 was $91.4 million, a decrease of 9.9% compared with $101.5 million in the prior year period. U.S. permanent implant procedures decreased by 7.0% compared ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Researchers used high-speed X-ray imaging to capture laser-metal interactions in less than a millisecond.

Scavilla announced the acquisition of Nevro Corporation for $250 million, aimed at expanding Globus' reach into the $2 billion neuromodulation market. He stated, "Nevro technology offers ...

The company made another M&A play this month with its planned acquisition of spinal cord stimulation (SCS) company Nevro. “I’m proud of our team at Globus Medical, delivering incredible ...

Neuralink's brain implant chip, 'the Link,' connects human brains to computers, aiding those with paralysis in movement control. Neuralink’s brain implant chip is a bold step toward merging ...

Shares of NYSE NVRO opened at $5.72 on Tuesday. The company has a fifty day moving average price of $4.48 and a 200 day moving average price of $4.98. The firm has a market cap of $214.14 million ...

Notably, Nevro also has a comprehensive portfolio of sacroiliac joint fusion implants.